The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC

Convection-Enhanced Delivery of Nanoliposomal Irinotecan for Recurrent Glioblastoma or High-Grade Glioma

Nicholas Butowski, MD
Published Online: 10:04 PM, Thu November 20, 2014
Nicholas Butowski, MD, associate professor, University of California, San Francisco, neuro-oncologist, UCSF Medical Center, discusses a phase I study of convection-enhanced delivery of nanoliposomal irinotecan (MM-398) for the treatment of recurrent glioblastoma or recurrent high-grade glioma.

Clinical Pearls

  • 1-3 catheters co-deliver liposomal-irinotecan and gadolinium into a patient’s tumor.
  • Gadolinium is used so that imaging can be done in real-time.
  • This process is unique because it bypasses systemic toxicity and ensures that the drug is administered properly.

<<< View more from the 2014 SNO meeting

Copyright © TargetedOnc 2019 Intellisphere, LLC. All Rights Reserved.